Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceutical companies ranked by net assets, at CZK 1.92T, ahead of Johnson & Johnson (CZK 1.81T) and Sanofi (CZK 1.76T). Figures as of 18 Nov 2026, 18:19 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerCZK 1.92T
- Median
- CZK 19.5B
- Combined market value
- CZK 113.21T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | CZK 1.92T | CZK 3.57T | CZK 626.62 | 0.97% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | CZK 1.81T | CZK 14.76T | CZK 6,131.77 | 1.00% down | 38% up | ||
| 3 | SanofiSNY · Health Care | CZK 1.76T | CZK 2.53T | CZK 1,052.00 | 0.41% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | CZK 1.17T | CZK 7.6T | CZK 3,084.00 | 3.21% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | CZK 1.16T | CZK 4.03T | CZK 2,327.03 | 0.00% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | CZK 1.08T | CZK 6.19T | CZK 3,993.76 | 1.41% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | CZK 1.03T | CZK 1.52T | CZK 475.83 | 1.06% down | 54% up | ||
| 8 | NovartisNVS · Health Care | CZK 1.03T | CZK 6.55T | CZK 3,466.71 | 1.98% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | CZK 694.7B | CZK 2.18T | CZK 21,079.92 | 0.97% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | CZK 640B | CZK 3.88T | CZK 880.65 | 2.64% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | CZK 589.7B | CZK 27.62T | CZK 31,008.41 | 1.44% down | 35% up | ||
| 12 | GSKGSK · Health Care | CZK 483.1B | CZK 2.17T | CZK 1,085.00 | 0.85% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | CZK 414.8B | CZK 3.03T | CZK 11,950.39 | 0.66% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | CZK 410.6B | CZK 2.73T | CZK 1,336.59 | 1.97% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | CZK 327B | CZK 527.6B | CZK 460.16 | 1.25% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | CZK 215.9B | CZK 886.7B | CZK 1,542.16 | 1.03% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 175.8B | CZK 1.09T | CZK 936.99 | 1.08% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | CZK 157.7B | CZK 551.3B | CZK 12,944.72 | 0.28% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | CZK 145.5B | CZK 299.7B | CZK 599.51 | 4.35% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | CZK 135.3B | CZK 261B | CZK 1,347.37 | 3.61% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | CZK 130B | CZK 128B | CZK 188.02 | 1.97% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | CZK 129.9B | CZK 705.8B | CZK 1,144.68 | 0.88% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | CZK 100.6B | CZK 621.1B | CZK 857.20 | 0.36% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | CZK 96.9B | CZK 1.03T | CZK 9,019.41 | 1.80% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | CZK 96B | CZK 351.9B | CZK 5,482.59 | 2.48% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 89.2B | CZK 278.6B | CZK 334.15 | 1.66% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | CZK 74B | CZK 769.8B | CZK 1,894.65 | 2.12% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | CZK 40.4B | CZK 175.1B | CZK 1,042.11 | 3.17% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | CZK 22.6B | CZK 133.2B | CZK 6,660.49 | 2.00% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | CZK 22.3B | CZK 69.9B | CZK 360.48 | 0.68% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | CZK 19.5B | CZK 191.4B | CZK 6,847.62 | 1.00% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | CZK 17.5B | CZK 449.9B | CZK 3,358.69 | 3.43% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | CZK 17.1B | CZK 141.9B | CZK 3,493.48 | 0.34% down | 31% up | ||
| 34 | InsmedINSM · Health Care | CZK 16.4B | CZK 587.5B | CZK 2,678.18 | 1.11% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | CZK 15.9B | CZK 203.9B | CZK 2,146.67 | 2.96% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | CZK 14.6B | CZK 187.4B | CZK 234.36 | 1.17% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | CZK 14.4B | CZK 222B | CZK 1,468.93 | 5.40% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | CZK 14.4B | CZK 166.3B | CZK 1,519.72 | 2.41% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | CZK 14.1B | CZK 108.8B | CZK 625.18 | 1.01% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | CZK 13.7B | CZK 181.9B | CZK 2,786.52 | 0.57% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | CZK 13.4B | CZK 210.1B | CZK 9,045.75 | 3.55% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 12.6B | CZK 166.3B | CZK 2,116.67 | 0.14% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | CZK 11.6B | CZK 101.6B | CZK 927.65 | 0.71% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | CZK 11.2B | CZK 162.7B | CZK 1,858.64 | 1.86% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | CZK 11B | CZK 109B | CZK 1,934.87 | 0.09% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | CZK 10.9B | CZK 101.8B | CZK 611.18 | 2.00% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | CZK 10.5B | CZK 145.6B | CZK 2,146.79 | 0.29% up | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | CZK 10.4B | CZK 136.8B | CZK 967.88 | 1.30% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | CZK 7.4B | CZK 88B | CZK 642.51 | 1.60% down | 169% up | ||
| 50 | ErascaERAS · Health Care | CZK 7.2B | CZK 103.6B | CZK 295.14 | 4.39% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | CZK 7B | CZK 133.8B | CZK 2,049.22 | 0.28% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | CZK 3.1B | CZK 182.9B | CZK 2,638.17 | 1.80% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | CZK 2.6B | CZK 109B | CZK 1,135.45 | 0.02% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | CZK 2B | CZK 157.2B | CZK 2,988.10 | 1.10% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -CZK 1.6B | CZK 170.5B | CZK 489.39 | 4.26% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -CZK 2.7B | CZK 116.4B | CZK 2,757.52 | 1.25% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -CZK 4B | CZK 396.4B | CZK 6,043.20 | 0.27% up | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -CZK 4.6B | CZK 112.1B | CZK 1,341.81 | 0.02% up | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -CZK 14.7B | CZK 159.3B | CZK 1,143.90 | 0.35% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -CZK 46.4B | CZK 338B | CZK 1,735.30 | 1.67% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -CZK 72.7B | CZK 11.31T | CZK 6,399.57 | 1.66% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2246 CZK).
Questions and answers
Which pharmaceutical companies rank first by net assets?
Pfizer (CZK 1.92T), Johnson & Johnson (CZK 1.81T) and Sanofi (CZK 1.76T) are the top three of the 61 pharmaceutical companies ranked by net assets as of 18 Nov 2026, 18:19 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of CZK 113.21T as of 18 Nov 2026, 18:19 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.